Stockscreener 앱 받기
6.84
3.64%
0.24
시장 영업 전:
6.84
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
How liquid is Xeris Biopharma Holdings Inc. stockSpeedy Gain Trade Picks - thegnnews.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Wyckoff Accumulation Phase Possible in Xeris Biopharma Holdings Inc.Potential Breakout Stock List Published This Week - beatles.ru
Xeris Biopharma Holdings Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2025 Earnings Call Transcript - Insider Monkey
XERS (Xeris Biopharma Holdings) Momentum Rank : 3 (As of Aug. 08, 2025) - GuruFocus
XERS Crosses Above Average Analyst Target - Nasdaq
Xeris Biopharma Reports Strong Q2 2025 Results - TipRanks
Beyond the Balance Sheet: What SWOT Reveals About Xeris Biopharm - GuruFocus
Xeris raises 2025 revenue guidance to $280M–$290M following 49% Q2 growth, led by Recorlev - MSN
Xeris Biopharma Holdings, Inc. SEC 10-Q Report - TradingView
Xeris Biopharma: Q2 Earnings Snapshot - The Washington Post
Xeris Biopharma Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Little Excitement Around Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Revenues - 富途牛牛
Xeris (XERS) Q2 Revenue Jumps 49% - The Motley Fool
Xeris Biopharma (XERS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Xeris Biopharma shares rise 24.23% premarket after beating Q2 revenue expectations and raising FY guidance. - AInvest
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance - BioSpace
Earnings Flash (XERS) Xeris Biopharma Posts Q2 Net Loss $0.01 a Share, vs. FactSet Est of $0.05 Loss - MarketScreener
Xeris Biopharma beats Q2 revenue expectations, raises FY guidance - MarketScreener
Institutional scanner results for Xeris Biopharma Holdings Inc.Trade Flow Monitor with Volume Tracker - Newser
Can trapped investors hope for a rebound in Xeris Biopharma Holdings Inc.Conservative Asset Allocation Risk Analysis - Newser
Xeris Biopharma Holdings Inc. stock trend outlook and recovery pathSmart Trend Analysis With Buy Point Cues - Newser
Is Xeris Biopharma Holdings Inc. building a consolidation baseBuy Alert Based on RSI and Volume - Newser
Xeris Pharmaceuticals Receives Buy Rating from Craig-Hallum, Analyst Consensus Remains Strong Buy with $6.00 Average Price Target. - AInvest
What are the technical indicators suggesting about Xeris Biopharma Holdings Inc.Sky-high return potential - Jammu Links News
Is Xeris Biopharma Holdings Inc. a good long term investmentOverwhelming financial success - Jammu Links News
Why is Xeris Biopharma Holdings Inc. stock attracting strong analyst attentionAchieve explosive financial results today - Jammu Links News
What catalysts could drive Xeris Biopharma Holdings Inc. stock higher in 2025Capitalize on fast-growing stocks today - Jammu Links News
Is Xeris Biopharma Holdings Inc. a growth stock or a value stockAchieve impressive returns with smart timing - Jammu Links News
Should I hold or sell Xeris Biopharma Holdings Inc. stock in 2025Get exclusive access to professional stock picks - Jammu Links News
Xeris Biopharma Holdings Inc. Stock Support and Resistance Levels You Should KnowEarnings Based Stock Performance Forecast - Newser
When is Xeris Biopharma Holdings Inc. stock expected to show significant growthPost Market Recommendation For 2025 - Jammu Links News
Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace
Why Xeris Biopharma Holdings Inc. stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
What is Xeris Biopharma Holdings Inc. company’s growth strategyMarket Forecast Alerts Backed By Experts - Jammu Links News
How strong is Xeris Biopharma Holdings Inc. company’s balance sheetStock Strategy Trend Scanner For Every Investor - Jammu Links News
What makes Xeris Biopharma Holdings Inc. stock price move sharplyProfitable Trading Blueprint with Entry Zones - Newser
Key External Factors That Drive Xeris Biopharma Holdings Inc. Stock Price MovementsHigh Yield Stock Screening Results Explained - metal.it
0.24%
3.39%
자본화:
|
볼륨(24시간):